ArticleJournal of cancer research and clinical oncology2023

TP53 or CDKN2A/B covariation in ALK/RET/ROS1-rearranged NSCLC is associated with a high TMB, tumor immunosuppressive microenvironment and poor prognosis.

Bin Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.